Trending Now
Exelis Inc. (NASDAQ:EXEL) And Iconic Therapeutics Release Promising Data On ICON-2...
Exelis Inc. (NASDAQ:EXEL) and Iconic Therapeutics have announced new preclinical data supporting the continued development of ICON-2 in the treatment of different solid tumors....
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aikido Pharma Inc (NASDAQ: AIKI) Issues Update on Partnership With Cedars-...
Aikido Pharma Inc (NASDAQ: AIKI) recently issued an operational update to its shareholders by announcing the execution of a partnership. The company executed a...
MAKE IT MODERN
LATEST REVIEWS
Oragenics, Inc (NYSE:OGEN) Inks A Pact With Biodextris Inc To...
Oragenics, Inc (NYSE:OGEN) entered an accord with Biodextris Inc in March 2021. As per the terms of the pact, Oragenics will use three IMAs...
MAKE IT MODERN
PERFORMANCE TRAINING
Data from an Ongoing Phase II Basket Trial of neratinib in HER2-mutated Cancers Published;...
Results from the Phase II SUMMIT study evaluating the safety and efficacy of neratinib in HER2-mutated cancers have been published. According to Puma Biotechnology...
Denison Mines Corp (NYSEAMERICAN: DNN) Gains 50% Ownership of JCU for $41 Million in...
Denison Mines Corp (NYSEAMERICAN: DNN) has gained 50% ownership of JCU Exploration Company. It is pretty excited to complete the acquisition, paying $20.5 million...
REGENXBIO Inc. (NASDAQ:RGNX) Reports $98.9 Million in Q3 2020 Revenue Driven By Zolgensma Milestone...
REGENXBIO Inc. (NASDAQ:RGNX) has announced its financial results and corporate highlights for the three months ended September 2020.
REGENXBIO received $80 Million in milestone payment...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) Releases Update On SRP-9001 Gene Therapy Program In Duchenne Muscular...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) has announced the completion of a Type C 'written response only' meeting with the FDA's Centre for Biologics Evaluation and...
PDL BioPharma Inc (NASDAQ:PDLI) Signs a Definitive Agreement with SWK Holdings Corporation for the...
PDL BioPharma Inc (NASDAQ:PDLI) was founded as Protein Design Labs, Inc. in 1986. Its founders were motivated by the need to impact patients living...
MAKE IT MODERN
